Editorial: Severe bleeding events among critically ill patients with hematological malignancies

Editorial: Severe bleeding events among critically ill patients with hematological malignancies

Saved in:

Bibliographic Details
Main Authors:	Nathan D. Nielsen, Jean-Marc Tadié, Raphaël Clere-Jehl
Format:	Article
Language:	English
Published:	SpringerOpen 2024-11-01
Series:	Annals of Intensive Care
Online Access:	https://doi.org/10.1186/s13613-024-01401-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Significant Progress in CAR T-Cell Therapy for Difficult-to-Treat Hematologic Malignancies
by: Raphaël Stadelmann, et al.
Published: (2022-10-01)

Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01)

Targeting splicing for hematological malignancies therapy
by: Monika Szelest, et al.
Published: (2024-11-01)

DETERMINATION OF FREQUENCY AND RISK FACTORS OF SECONDARY MALIGNANCY DEVELOPMENT IN HEMATOLOGICAL MALIGNANCIES
by: Ennur Ramadan, et al.
Published: (2024-12-01)

Analysis of Adverse Events during Intrahospital Transportation of Critically Ill Patients
by: Francielli Mary Pereira Gimenez, et al.
Published: (2017-01-01)

VISTA in hematological malignancies: a review of the literature
by: Yuanjia Duan, et al.
Published: (2024-12-01)

GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE
by: Francesco Fabozzi, et al.
Published: (2023-04-01)

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
by: Pradyumna Agasthi, et al.
Published: (2018-01-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HEMATOLOGICAL MALIGNANCIES
by: Gokhan Sargin, et al.
Published: (2014-08-01)

RNA modification in normal hematopoiesis and hematologic malignancies
by: Xi Chen, et al.
Published: (2024-11-01)

ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
by: Daniel Olson, et al.
Published: (2014-08-01)

γδ T cells in hematological malignancies: mechanisms and therapeutic strategies
by: Xingchi Chen, et al.
Published: (2025-01-01)

CAR-T Therapy Beyond B-Cell Hematological Malignancies
by: Martina Canichella, et al.
Published: (2025-01-01)

Clinical advances in antibody-drug conjugates for hematological malignancies
by: TANG Sijie, et al.
Published: (2024-12-01)

THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES
by: Giovanni Roti, et al.
Published: (2019-06-01)

RESPIRATORY VIRAL INFECTIONS IN CHILDREN AND ADOLESCENTS WITH HEMATOLOGICAL MALIGNANCIES
by: Seung Beom Han, et al.
Published: (2019-01-01)

Radiotherapy Can Cause Haemostasis in Bleeding Skin Malignancies
by: Helena Sung-In Jang, et al.
Published: (2012-01-01)

PET/CT in the Evaluation of CAR-T Cell Immunotherapy in Hematological Malignancies
by: Shashi B. Singh MBBS, et al.
Published: (2024-05-01)

BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES
by: Giuseppe Leone, et al.
Published: (2015-10-01)

A rare threat to patients with hematological malignancies: Saprochaete clavata
by: Elif Özge Damar Mıdık, et al.
Published: (2024-12-01)

Prevalence, trends, and outcomes of hematological malignancies in patients with hemophagocytic lymphohistiocytosis
by: Qi Zhang, et al.
Published: (2024-12-01)

Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies
by: Gazmend Temaj, et al.
Published: (2024-10-01)

Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
by: Amirata Mohseni, et al.
Published: (2025-01-01)

Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?
by: Gregorios Christodoulidis, et al.
Published: (2020-01-01)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
by: William A. Fabricius, et al.
Published: (2016-01-01)

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
by: Zhongfei Tao, et al.
Published: (2024-12-01)

Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
by: Samira Anvari, et al.
Published: (2024-12-01)

Fournier's Gangrene Complicating Hematologic Malignancies: Literature Review and Treatment Suggestions
by: Giovanni D'Arena, et al.
Published: (2013-11-01)

Multimodality imaging of hematologic malignancies affecting the breast: a pictorial essay
by: Natalia Guerrero-Fajardo, et al.
Published: (2024-10-01)

Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies
by: Junko Okabe-Kado, et al.
Published: (2012-01-01)

Frequency and Treatment Outcome of Invasive Fungal Infections in Children with Hematological Malignancies
by: Rabiha Manzoor, et al.
Published: (2025-01-01)

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01)

Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review
by: Liyun Gao PhD, et al.
Published: (2024-11-01)

Short-term and long-term outcomes of critically ill patients with solid malignancy: a retrospective cohort study
by: Su Yeon Lee, et al.
Published: (2024-11-01)

Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients
by: Aleksandar R. Zivkovic, et al.
Published: (2015-01-01)

Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients
by: Hidetaka Matsuda, et al.
Published: (2020-01-01)

Care of the Critically ill /
Published: (1974)

The Effect of Atorvastatin on Oncogenic miRNAs in Hematological Malignancies: A Central Study
by: Jood Hashem, et al.
Published: (2024-12-01)

The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
by: Alan Hodges, et al.
Published: (2024-12-01)

The Role of Machine Learning in the Most Common Hematological Malignancies: A Narrative Review
by: Teresa Perillo, et al.
Published: (2024-09-01)